CytoSure® is a collection of products that have been developed with input from leaders in the fields of cytogenetics, cancer and rare disease research – which have been optimised to provide the most relevant content and sensitivity.
OGT has over two decades' experience in the development of microarrays and we have used that experience to provide CytoSure arrays for investigating a large range of disease phenotypes, with excellent CNV and LOH calling, down to the exon level.
CytoSure has expanded to include NGS platforms for cytogenetic and rare disease research that have the same superior CNV calling as the arrays but also the added benefit of SNV and Indel calling.
Both the arrays and NGS platforms are supported by complimentary analytical software, CytoSure Interpret and Interpret, respectively. These software packages have been developed at OGT and have been designed to be adaptable and user-friendly.